Genetic Frontotemporal Dementia Initiative for Neurodevelopment

NCT05779813 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-04-03

No results posted yet for this study

Summary

This is an international multi-centre cohort study of first and second degree family members of individuals who carry Frontotemporal Dementia (FTD) mutations in MAPT, GRN or C9ORF72 repeat expansions for youths between the ages 9-17.

Conditions

  • Frontotemporal Dementia
  • Family Members

Sponsors & Collaborators

  • Western University

    lead OTHER

Principal Investigators

  • Elizabeth Finger, MD · Western University

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2033-03-31
Completion
2035-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05779813 on ClinicalTrials.gov